The randomized trial row states there is limited condition-specific data because most GLP-1 trials excluded patients with inflammatory bowel disease, and draws the implication that the safety profile in ulcerative colitis is simply unknown
Common Side Effects and Safety Considerations The most frequently reported side effects are gastrointestinal particularly nausea and are generally mild to moderate, most prominent during dose escalation, and tend to diminish over time
Ensemble, ces mcanismes justifient scientifiquement l'utilisation du glutathion dans les produits claircissants modernes, ce qui en fait un actif prcieux pour les srums, essences, crmes et ampoules visant un claircissement sr, progressif et multidimensionnel
doi: 10.2147/DDDT.S470826 Holst JJ
Potential Side Effects and Safety Considerations The most common side effects are gastrointestinal including nausea, vomiting, and diarrhoea and are most pronounced during dose escalation
We also measure your body mass index (BMI) and check for any preexisting conditions